Liverly - Mixed Reality Liver Disease Therapeutics

Liverly is one of the first mixed reality therapeutic tools in the world designed for Nonalcoholic Fatty Liver Disease (NAFLD), a chronic condition affecting 32% of the global population with no pharmaceutical treatments available. Offering a unique, non-invasive experience that harnesses research in circadian rhythm and autophagy to support liver health. Liverly’s spatial therapeutics approach empowers users to take charge of their liver health in a groundbreaking way.